Abstract
Background/Objectives:
Oat bran shows cholesterol-lowering properties, but its effects on other cardiovascular risk markers are less frequently investigated. This study examined the effects of oat bran on blood lipids, hemostatic factors and energy utilization.
Subjects/Methods:
A double-blind, randomized crossover study in 24 adults (age 25.2±2.7 years; body mass index: 24.9±2.9 kg/m2), who completed two 2-week dietary intervention periods: low-fiber diet (control) or an oat bran (control +102 g oat bran/day) diet. Fasting blood samples were drawn before and after each period, and 3-day fecal samples were collected during the last week of each period.
Results:
Total cholesterol decreased by 14% during the oat bran period compared with 4% during the control period (P<0.001). Non-high-density lipoprotein (HDL) cholesterol decreased by 16% in the oat bran period compared with 3% in the control period (P<0.01), as did total triacylglycerol (21 vs 10%, P<0.05) and very-low-density lipoprotein triacylglycerol 33 vs 9%, P<0.01). Plasminogen activator inhibitor-1 (PAI-1) and factor VII (fVII) levels decreased more during consumption of oat bran compared with the control period (PAI-1: 30 vs 2.3%, P<0.01; fVII: 15 vs 7.6%, <0.001). Fecal volume and dry matter were greater when consuming the oat bran diet compared with the control (P<0.001), and energy excretion was increased by 37% (1014 vs 638 kJ/day, P<0.001); however, changes in body weight did not differ (oat bran:−0.3±0.5 kg; control: 0.0±0.7 kg).
Conclusions:
Addition of oat bran (6 g soluble fiber/day) to a low-fiber diet lowered total and non-HDL cholesterol, as well as hemostatic factors, and may affect energy balance through reduced energy utilization.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials
European Journal of Nutrition Open Access 03 January 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Aman P, Rimsten L, Andersson R (2004). Molecular weight distribution of β-glucan in oat-based foods. Cereal Chem 81, 356–360.
Astrup A, Kristensen M, Gregersen NT, Belza A, Lorenzen JK, Due A et al. (2010). Can bioactive foods affect obesity? Ann NY Acad Sci 1190, 25–41.
Bazzano LA, Song Y, Bubes V, Good CK, Manson JE, Liu S (2005). Dietary intake of whole and refined grain breakfast cereals and weight gain in men. Obes Res 13, 1952–1960.
Berg A, König D, Deibert P, Grathwohl D, Berg A, Baumstark MW et al. (2003). Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk. A controlled randomized lifestyle intervention study. Ann Nutr Metab 47, 306–311.
Brown L, Rosner B, Willett WW, Sacks FM (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30–42.
Calloway DH, Kretsch MJ (1978). Protein and energy utilization in men given a rural Guatemalan diet and egg formulas with and without added oat bran. Am J Clin Nutr 31, 1118–1126.
Cara L, Dubois C, Borel P, Armand M, Senft M, Portugal H et al. (1992). Effects of oat bran, rice bran, wheat fiber, and wheat germ on postprandial lipemia in healthy adults. Am J Clin Nutr 55, 81–88.
Chapman MJ, Goldstein S, Lagrange D, Laplaud PM (1981). A density gradient ultra-centrifugal procedure for the isolation of the major lipoprotein classes from human-serum. J Lipid Res 22, 339–358.
Chen HL, Haack VS, Janecky CW, Vollendorf NW, Marlett JA (1998). Mechanisms by which wheat bran and oat bran increase stool weight in humans. Am J Clin Nutr 68, 711–719.
Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS et al. (2001). Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161, 1413–1419.
de Groot A, Luyken R, Pikaar NA (1963). Cholesterol-lowering effect of rolled oats. Lancet 2, 303–304.
Djousse L, Ellison RC, Zhang Y, Arnett DK, Sholinsky P, Borecki I (1998). Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 68, 568–575.
Dubois C, Armand M, Senft M, Portugal H, Pauli AM, Bernard PM et al. (1995). Chronic oat bran intake alters postprandial lipemia and lipoproteins in healthy adults. Am J Clin Nutr 61, 325–333.
EFSA Panel on Dietetic Products (2009). Scientific opinion on the substantiation of health claims related to beta-glucans and maintenance of normal blood cholesterol concentrations (ID 754, 755, 801, 1465, 2934) and maintenance or achievement of a normal body weight (ID 820, 823) pursuant to article 13 (1) of Regulation (EC) No 1924/2006. EFSA Journal 7, 1254.
Gorog DA (2010). Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease. J Am Coll Cardiol 55, 2701–2709.
Hill JO (2006). Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 27, 750–761.
Koh-Banerjee P, Franz M, Sampson L, Liu S, Jacobs Jr DR, Spiegelman D et al. (2004). Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr 80, 1237–1245.
Landin K, Holm G, Tengborn L, Smith U (1992). Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr 56, 1061–1065.
Lefevre M, Kris-Etherton PM, Zhao G, Tracy RP (2004). Dietary fatty acids, hemostasis, and cardiovascular disease risk. J Am Diet Assoc 104, 410–419.
Liu L, Zhao SP, Wen T, Zhou HN, Hu M, Li JX (2008). Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients. Coron Artery Dis 19, 145–151.
Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G (2003). Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78, 920–927.
Miles CW, Kelsay JL, Wong NP (1988). Effect of dietary fiber on the metabolizable energy of human diets. J Nutr 118, 1075–1081.
Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL et al. (2004). Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164, 370–376.
Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT (1996). Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96, 1254–1261.
Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E et al. (2007). Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 14, 203–212.
Rigaud D, Ryttig KR, Leeds AR, Bard D, Apfelbaum M (1987). Effects of a moderate dietary fibre supplement on hunger rating, energy input and faecal energy output in young, healthy volunteers. A randomized, double-blind, cross-over trial. Int J Obes 11 (Suppl 1), 73–78.
Robinson JG, Wang S, Smith BJ, Jacobson TA (2009). Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol 53, 316–322.
Saltzman E, Das SK, Lichtenstein AH, Dallal GE, Corrales A, Schaefer EJ et al. (2001). An oat-containing hypocaloric diet reduces systolic blood pressure and improves lipid profile beyond effects of weight loss in men and women. J Nutr 131, 1465–1470.
Sandstrom B, Bugel S, McGaw BA, Price J, Reid MD (2000). A high oat-bran intake does not impair zinc absorption in humans when added to a low-fiber animal protein-based diet. J Nutr 130, 594–599.
Sundell IB, Ranby M (1993). Oat husk fiber decreases plasminogen activator inhibitor type 1 activity. Haemostasis 23, 45–50.
Theuwissen E, Mensink RP (2008). Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 94, 285–292.
US Food and Drug Administration (1997). FDA final rule for federal labeling: health claims: oats and coronary heart disease. Fed Regist 62, 3584–3681.
Van Gaal LF, Mertens IL, De Block CE (2006). Mechanisms linking obesity with cardiovascular disease. Nature 444, 875–880.
Venter CS, Vorster HH (1989). Possible metabolic consequences of fermentation in the colon for humans. Med Hypotheses 29, 161–166.
Wisker E, Bach Knudsen KE, Daniel M, Feldheim W, Eggum BO (1996). Digestibilities of energy, protein, fat and nonstarch polysaccharides in a low fiber diet and diets containing coarse or fine whole meal rye are comparable in rats and humans. J Nutr 126, 481–488.
Wolever TM, Tosh SM, Gibbs AL, Brand-Miller J, Duncan AM, Hart V et al. (2010). Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Am J Clin Nutr 92, 723–732.
World Health Organization (1985). Energy and protein requirements. Report of a Joint FAO/WHO/UNU Consultation, p 724.
Acknowledgements
We gratefully acknowledge dietitian Hanne Mary Jensen, lab technician Hanne Lysdal Petersen, Kitchen assistants Karina Graft Rossen and Ingelise Lundgaard for their dedicated assistance with the practical work, and the volunteers for participating in the studies. The study was supported by a grant from the Faculty of Life Sciences, University of Copenhagen.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kristensen, M., Bügel, S. A diet rich in oat bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers. Eur J Clin Nutr 65, 1053–1058 (2011). https://doi.org/10.1038/ejcn.2011.102
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2011.102
Keywords
- oat bran
- β-glucan
- blood lipids
- obesity
- apparent digestibility
- hemostasis
This article is cited by
-
Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials
European Journal of Nutrition (2022)
-
A high intake of dietary fiber influences C-reactive protein and fibrinogen, but not glucose and lipid metabolism, in mildly hypercholesterolemic subjects
European Journal of Nutrition (2014)